Anteris Technologies Global Corp. (AVR:NASD)の戦略的SWOTと財務分析

Report Overview

Report Summary

Anteris Technologies Global Corp. Strategic SWOT Analysis and Financial Insights – A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, and Recent Trends Report is a comprehensive and easily accessible overview of Anteris Technologies Global Corp.’s business operations. It provides a detailed analysis of the company’s financial and strategic standing, as well as its position in the industry compared to competitors. The report includes several key features to facilitate decision-making and provide insights into the company’s performance.

The report begins with in-depth information about Anteris Technologies Global Corp. including key insights, business segments, key executives, locations, products and services, historical events, corporate strategy, and management discussions. This section provides a solid foundation for understanding the company’s key attributes.

Next, the report assesses Anteris Technologies Global Corp.’s strategic standing through various analyses. The ESG spotlight evaluates the company’s environmental, social, and governance performance, providing insights into its sustainability efforts and ethical practices. The SWOT analysis examines the company’s internal strengths and weaknesses, as well as external opportunities and threats. Additionally, By integrating these strategic analyses, the report offers a comprehensive understanding of Anteris Technologies Global Corp.’s overall strategic standing and supports informed decision-making and strategic planning.

The report also covers Anteris Technologies Global Corp.’s financial analysis basis of latest income statement, balance sheet, and cash flow statement. Key financial ratios related to profitability, asset turnover, credit, market, and long-term solvency are outlined, providing guidance for investment decisions. Furthermore, the report compares Anteris Technologies Global Corp.’s financial parameters with those of its competitors, offering a unique analysis of the competitive landscape. This information helps manage the business environment and improve sales activities by gaining insight into competitors’ operations.

Finally, the report includes recent news and deal activities undertaken by Anteris Technologies Global Corp. enhancing awareness of the company’s business trends, growth perspectives, and more.

Key Highlights

Anteris Technologies Global Corp is Founded in 1999, a global medical technology company focused on advancing cardiac care through science-driven innovation. The company traces its origins back more than 40 years, beginning with early physician-led research into tissue technologies after animal-based materials were found to calcify over time. This long history of experimental and clinical research led to the development of a patented anti-calcification ADAPT tissue that has demonstrated calcium-free performance for up to 10 years and has been used in more than 55,000 patients worldwide as a cardiac and vascular patch. Anteris is headquartered in Australia, with operations and clinical collaborations extending across the United States, Canada, Europe, and selected global markets. The core business of Anteris centers on structural heart technologies, particularly solutions for aortic stenosis. Its flagship innovation is the DurAVR Transcatheter Heart Valve, a single-piece biomimetic valve designed to mimic native heart valve physiology and restore healthy blood flow patterns. The company focuses on addressing clinical gaps in existing Transcatheter Aortic Valve Replacement therapies, especially for younger and more active patients. Anteris maintains a strong global presence through clinical trials involving 80 centers, physician partnerships, and active engagement with regulators and investors. The company is supported by a values-driven culture emphasizing accountability, integrity, teamwork, and innovation, alongside programs promoting gender equality and leadership development in science.

Anteris Technologies Global Corp. in the News:-

2025-06-09 – Anteris Appoints David Roberts and Gregory Moss to its Board of Directors
2025-03-31 – Anteris Technologies Reaches Clinical Milestone: 100 patients treated with DurAVR THV
2025-03-21 – Anteris Reports One-Year Patient Outcomes for DurAVR THV
2025-02-28 – Anteris to Present at Healthcare Investor Conferences – TD Cowen and Barclays
2024-12-17 – Anteris Technologies Global Corp. Announces Closing of $88.8 Million U.S. Initial Public Offering

Scope

• Tactical Analysis:- Various strategic frameworks to gain insights into a Anteris Technologies Global Corp.’s competitive position and operational environment. These analytical tools assist in identifying competitive advantages, potential risks, and areas for improvement and efficiency, enabling companies to make informed tactical decisions.
• Business Strategy:- Contributes to shaping the Anteris Technologies Global Corp.’s overall direction, goals, and decision-making processes, ensuring long-term success and alignment with stakeholder expectations.
• Financial Position:- Provide valuable information on the financial performance and investor sentiment surrounding the company. Indicating the level of confidence and expectations in the company’s future prospects. These components collectively contribute to understanding the financial health and market perception of the company.
• Company Fundamentals:- These fundamentals offer valuable insights into the company’s history, operations, leadership, and geographical presence, aiding in a comprehensive understanding of the organization.
• Competitive Landscape:- An identification of the Anteris Technologies Global Corp.’s main competitors, providing insights into the competitive landscape it operates in.

Reasons to Buy

• Comprehensive Understanding of the Anteris Technologies Global Corp.’s internal and external factors through SWOT analysis, Financial Analysis, and Competitors Benchmarking.
• Strive Strategic Decision Making with various analyses and identifying potential customers and suppliers.
• Mitigate Risk with help of thorough analysis of internal and external factors. Furthermore, develop strategies and contingency plans to address these challenges and minimize their impact on business operations.
• Competitive Benchmarking will help to gain a competitive advantage by understanding industry trends, customer preferences, and best practices.
• Financial Performance Evaluation provides crucial insights into key financial ratios and trends, supporting better financial decision-making and resource allocation.
• Valuable insights from the report enable investors and partners to make informed decisions regarding potential Collaborations, Investments, or Partnerships with the company.

Additionally, available deep-dive analysis on the company Anteris Technologies Global Corp.:

• Anteris Technologies Global Corp. PESTLE Analysis
• Anteris Technologies Global Corp. Value Chain Analysis
• Anteris Technologies Global Corp. Porter’s Five Forces Analysis
• Anteris Technologies Global Corp. VRIO Analysis
• Anteris Technologies Global Corp. BCG Analysis
• Anteris Technologies Global Corp. Segmentation, Targeting and Positioning (STP) Analysis
• Anteris Technologies Global Corp. Ansoff Matrix Analysis

Table of Contents

Table of Contents 2
Tables 5
Charts 6
Anteris Technologies Global Corp. – Key Company Facts 7
Anteris Technologies Global Corp. – Company Description 8
Anteris Technologies Global Corp. – Top Executives 9
Anteris Technologies Global Corp. – Head Office & Locations 10
Head Office – Country 10
Anteris Technologies Global Corp. – Products and Services 11
Products 11
Services 12
Anteris Technologies Global Corp. – Corporate Strategy 13
Anteris Technologies Global Corp. – Business Description 16
Development and Commercialization of ADAPT Anti Calcification Tissue 16
Anteris Technologies Global Corp. – ESG Spotlight 18
Environment 18
Social 19
Corporate Governance 19
Anteris Technologies Global Corp. – SWOT Analysis 21
Overview 21
Strengths 23
Weaknesses 25
Opportunities 27
Threats 29
Anteris Technologies Global Corp. – Financial Deep Dive 31
Share Price Trend – Jun-2025 to Jun-2026 (Average Share Closing Price) 31
Profit and Loss Statement 33
Summary of Profit and Loss Statement 33
Balance Sheet 38
Summary of Balance Sheet 38
Cash Flow Statement 43
Summary of Cash Flow Statement 43
Key Financial Ratio Analysis 48
Anteris Technologies Global Corp. – Ratio Charts 50
Activity Ratio Charts 50
Growth Ratios Charts 51
Leverage Ratio Charts 55
Liquidity Ratio Charts 57
Profitability Ratio Charts 59
Competing Players 61
Snapshot of Competing Players 62
Abbott Laboratories 62
Key Company Facts 62
Company Description 62
Abbott Laboratories – SWOT Spotlight 63
Abbott Laboratories – PESTLE Spotlight 65
Key Financials 68
Share Price Trend – Jun-2025 to Jun-2026 (Average Share Closing Price) 68
Key Financial Ratio Analysis 73
Boston Scientific Corporation 75
Key Company Facts 75
Company Description 75
Boston Scientific Corporation – SWOT Spotlight 76
Boston Scientific Corporation – PESTLE Spotlight 78
Key Financials 80
Share Price Trend – Jun-2025 to Jun-2026 (Average Share Closing Price) 80
Key Financial Ratio Analysis 85
Edwards Lifesciences Corporation 87
Key Company Facts 87
Company Description 87
Edwards Lifesciences Corporation – SWOT Spotlight 88
Edwards Lifesciences Corporation – PESTLE Spotlight 90
Key Financials 92
Share Price Trend – Jun-2025 to Jun-2026 (Average Share Closing Price) 92
Key Financial Ratio Analysis 97
Medtronic plc 99
Key Company Facts 99
Company Description 99
Medtronic plc – SWOT Spotlight 100
Medtronic plc – PESTLE Spotlight 102
Key Financials 104
Share Price Trend – Jun-2025 to Jun-2026 (Average Share Closing Price) 104
Key Financial Ratio Analysis 109
Anteris Technologies Global Corp. – In the News 111
09-Jun-2025 – Anteris Appoints David Roberts and Gregory Moss to its Board of Directors 111
Appendix 112
Definitions 112
SWOT Analysis 112
PESTLE Analysis 112
Value Chain Analysis 112
ESG Spotlight 112
Financial Deep Dive 112
Financial Ratios 113
Activity Ratios 113
Growth Ratios 115
Leverage Ratios 118
Liquidity Ratios 120
Market Ratios 122
Profitability Ratios 124
Research Methodology 126
Disclaimer 127
Contact Us 127

List of Tables

Table 1: Anteris Technologies Global Corp. – Company Facts 7
Table 2: Anteris Technologies Global Corp. – Digital Presence 7
Table 3: Anteris Technologies Global Corp. – Top Executives 9
Table 4: Anteris Technologies Global Corp. – Products 11
Table 5: Anteris Technologies Global Corp. – Services 12
Table 6: Anteris Technologies Global Corp. – Share Price Trend – Jun-2025 to Jun-2026 31
Table 7: Anteris Technologies Global Corp. – Profit and Loss Statement – 2022-2025 35
Table 8: Anteris Technologies Global Corp. – Balance Sheet – 2022-2025 40
Table 9: Anteris Technologies Global Corp. – Cash Flow Statement – 2022-2025 45
Table 10: Anteris Technologies Global Corp. – Ratio Analysis – 2022-2025 48
Table 11: Anteris Technologies Global Corp. – Competing Players 61
Table 12: Competing Players – Abbott Laboratories – Key Company Facts 62
Table 13: Abbott Laboratories – Share Price Trend – Jun-2025 to Jun-2026 68
Table 14: Competing Players – Abbott Laboratories – Profit and Loss Statement – 2022-2025 70
Table 15: Abbott Laboratories – Balance Sheet 2022-2025 71
Table 16: Abbott Laboratories – Cash Flow Statement 2022-2025 72
Table 17: Abbott Laboratories – Ratio Analysis – 2022-2025 73
Table 18: Competing Players – Boston Scientific Corporation – Key Company Facts 75
Table 19: Boston Scientific Corporation – Share Price Trend – Jun-2025 to Jun-2026 80
Table 20: Competing Players – Boston Scientific Corporation – Profit and Loss Statement – 2022-2025 82
Table 21: Boston Scientific Corporation – Balance Sheet 2022-2025 83
Table 22: Boston Scientific Corporation – Cash Flow Statement 2022-2025 84
Table 23: Boston Scientific Corporation – Ratio Analysis – 2022-2025 85
Table 24: Competing Players – Edwards Lifesciences Corporation – Key Company Facts 87
Table 25: Edwards Lifesciences Corporation – Share Price Trend – Jun-2025 to Jun-2026 92
Table 26: Competing Players – Edwards Lifesciences Corporation – Profit and Loss Statement – 2022-2025 94
Table 27: Edwards Lifesciences Corporation – Balance Sheet 2022-2025 95
Table 28: Edwards Lifesciences Corporation – Cash Flow Statement 2022-2025 96
Table 29: Edwards Lifesciences Corporation – Ratio Analysis – 2022-2025 97
Table 30: Competing Players – Medtronic plc – Key Company Facts 99
Table 31: Medtronic plc – Share Price Trend – Jun-2025 to Jun-2026 104
Table 32: Competing Players – Medtronic plc – Profit and Loss Statement – 2022-2025 106
Table 33: Medtronic plc – Balance Sheet 2022-2025 107
Table 34: Medtronic plc – Cash Flow Statement 2022-2025 108
Table 35: Medtronic plc – Ratio Analysis – 2022-2025 109

List of Figures

Figure 1: Anteris Technologies Global Corp. – SWOT Analysis 22
Figure 2: Anteris Technologies Global Corp. – Average Share Price Trend – Jun-2025 to Jun-2026 32
Figure 3: Anteris Technologies Global Corp. – Profit and Loss Statement – 2022-2025 37
Figure 4: Anteris Technologies Global Corp. – Balance Sheet – 2022-2025 42
Figure 5: Anteris Technologies Global Corp. – Cash Flow Statement 2022-2025 47
Figure 6: Anteris Technologies Global Corp. – Activity Ratio Charts 50
Figure 7: Anteris Technologies Global Corp. – Growth Ratio Charts (Value %) 51
Figure 8: Anteris Technologies Global Corp. – Leverage Ratio Charts 55
Figure 9: Anteris Technologies Global Corp. – Liquidity Ratio Charts 57
Figure 10: Anteris Technologies Global Corp. – Profitability Ratio Charts (Value %) 59
Figure 11: Competing Players – Abbott Laboratories – SWOT Spotlight 64
Figure 12: Competing Players – Abbott Laboratories – PESTLE Spotlight 67
Figure 13: Abbott Laboratories – Average Share Price Trend – Jun-2025 to Jun-2026 69
Figure 14: Abbott Laboratories – Profit and Loss Statement – 2022-2025 70
Figure 15: Abbott Laboratories – Balance Sheet – 2022-2025 71
Figure 16: Abbott Laboratories – Cash Flow Statement 2022-2025 72
Figure 17: Competing Players – Boston Scientific Corporation – SWOT Spotlight 77
Figure 18: Competing Players – Boston Scientific Corporation – PESTLE Spotlight 79
Figure 19: Boston Scientific Corporation – Average Share Price Trend – Jun-2025 to Jun-2026 81
Figure 20: Boston Scientific Corporation – Profit and Loss Statement – 2022-2025 82
Figure 21: Boston Scientific Corporation – Balance Sheet – 2022-2025 83
Figure 22: Boston Scientific Corporation – Cash Flow Statement 2022-2025 84
Figure 23: Competing Players – Edwards Lifesciences Corporation – SWOT Spotlight 89
Figure 24: Competing Players – Edwards Lifesciences Corporation – PESTLE Spotlight 91
Figure 25: Edwards Lifesciences Corporation – Average Share Price Trend – Jun-2025 to Jun-2026 93
Figure 26: Edwards Lifesciences Corporation – Profit and Loss Statement – 2022-2025 94
Figure 27: Edwards Lifesciences Corporation – Balance Sheet – 2022-2025 95
Figure 28: Edwards Lifesciences Corporation – Cash Flow Statement 2022-2025 96
Figure 29: Competing Players – Medtronic plc – SWOT Spotlight 101
Figure 30: Competing Players – Medtronic plc – PESTLE Spotlight 103
Figure 31: Medtronic plc – Average Share Price Trend – Jun-2025 to Jun-2026 105
Figure 32: Medtronic plc – Profit and Loss Statement – 2022-2025 106
Figure 33: Medtronic plc – Balance Sheet – 2022-2025 107
Figure 34: Medtronic plc – Cash Flow Statement 2022-2025 108

---

---